Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

Gurfinkel M, Ke S, Wen X, Li C, Sevick-Muraca EM (2005) Near-infrared fluorescence optical imaging and tomography. Dis Markers 19:107–121

Adams KE, Ke S, Kwon S et al. (2007) Comparison of visible and near-infrared wavelength excitable fluorescent dyes for molecular imaging. J Biomed Optics 12:024017. doi: 12:024017-1-024017-9

Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215

Unno N, Inuzuka K, Suzuki M et al. (2007) Preliminary evidence with a novel fluorescence lymphography using indocyanine green fluorescence lymphography. J Vasc Surg 45:1016–1021

Tagaya N, Yamazaki R, Nakagawa A et al. (2008) Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 195:850–853

Unno N, Nishiyama M, Suzuki M et al. (2008) Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg 36:230–236

Sevick-Muraca EM, Sharma R, Rasmussen JC et al. (2008) Imaging of lymph flow in breast cancer patients following microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246:734–741

Rasmussen JC, Tan I-C, Marshall MV, Fife CE, Sevick-Muraca EM (2009) Lymphatic imaging in humans with near infrared fluorescence. Curr Opin Biotechnol 20:1–9

Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV (2006) Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13:1671–1681

Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM (2007) Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 48:1501–1510

Houston JP, Ke S, Wang W, Li C, Sevick-Muraca EM (2005) Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Optics 10:054010

Lillie LE, Temple NJ, Florence LZ (1996) Reference values for young normal Sprague-Dawley rats: weight gain, hematology, and clinical chemistry. Human and Exp Toxicol 15:612–616

Giknis MLA, Clifford CB (2006) Clinical Laboratory parameters for Crl:CD(SD) rats. Charles River Laboratories, pp 1–14

Ott P, Keiding S, Bass L (1993) Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Hepatology 18:1504–1515

Bax NDS, Tucker GT, Woods HF (1980) Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Br J Pharmacol 10:353–362

Klaassen CD, Plaa GL (1969) Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Tox Appl Pharmacol 15:374–384

Shah SM, Tatlpinar S, Quinlan E et al. (2006) Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography. Invest Ophthalmol Vis Sci 47:5460–5468

Sykes SO, Bressler NM, Maguire MG, Schachat AP, Bressler SB (1994) Detecting recurrent choroidal neovascularization: comparison of clinical examination with and without fluorescein angiography. Arch Ophthalmol 112:1561–1566

Takayama T, Wanibuchi Y, Suma H et al. (1991) Intraoperative coronary angiography using fluorescein. Ann Thorac Surg. 51:140–143

Takayama T, Wanibuchi Y, Suma H et al. (1992) Intraoperative coronary angiography using fluorescein: basic studies and clinical application. Vascular and Endovascular Surg 26:193–199

Yannuzzi LA, Flower RW, Slakter JS (1997) Indocyanine green angiography. Mosby Press, St. Louis

Agarwal A (2007) Fundus fluorescein and indocyanine green angiography: a textbook and atlas. Slack Inc., Thorofare

Ikagawa H, Yoneda M, Iwaki M et al. (2005) Chemical toxicity of indocyanine green damages retinal pigment epithelium. Invest Ophthalmol Vis Sci 46:2531–2539

Lüke C, Lüke M, Dietlein TS et al. (2005) Retinal tolerance to dyes. Br J Ophthalmol 89:1188–1191

Schuettauf F, Haritoglou C, May CA et al. (2006) Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 47:3573–3578

Gandorfer A., Haritoglou C., Gandorfer A et al. (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44:316–323

Hope-Ross M, Yannuzzi LA, Gragoudas ES et al. (1994) Adverse reactions due to indocyanine green. Ophthalmology 101:529–533

Obana A, Miki M, Havashi K et al. (1994) Survey of complications of indocyanine green angiography in Japan. Am J Ophthalmol 118:749–753

Raabe A, Nakaji P, Beck J et al. (2005) Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. J Neurosurg 103:982–989

Withrow KP, Gleysteen BS, Safavy A, Skipper J, Desmond RA, Zinn K, Rosenthal EL (2007) Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol-Head Neck Surg 137:729–734